Join me as I share insights from our studies at Opticyte with all those attending the upcoming Optica MedTech Industry Summit in Montreal! 🔬🏥
I’ll present our latest findings on how our VitalO₂ monitor technology is poised to help revolutionize care for sepsis, anemia, and vasoplegia. Our studies show promising results in detecting oxygen deficiency and helping doctors make quick, informed decisions.
Did you know that 20-25% of cardiac surgery patients develop a complication known as vasoplegia? Our technology aims to help address this critical condition that can lead to long hospital and ICU stays and increased risk of death.
I’ll be spending time connecting with fellow innovators and clinicians to explore how optics can transform healthcare. Let’s continue to build a community that broadens inclusivity and helps drive continued improvements in patient outcomes.